1. Home
  2. GBX vs HRMY Comparison

GBX vs HRMY Comparison

Compare GBX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

HOLD

Current Price

$52.55

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$29.38

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBX
HRMY
Founded
1974
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GBX
HRMY
Price
$52.55
$29.38
Analyst Decision
Sell
Buy
Analyst Count
2
10
Target Price
$49.00
$46.70
AVG Volume (30 Days)
465.4K
605.9K
Earning Date
04-07-2026
05-05-2026
Dividend Yield
2.57%
N/A
EPS Growth
28.02
7.97
EPS
1.62
2.71
Revenue
$3,240,200,000.00
$868,453,000.00
Revenue This Year
N/A
$19.75
Revenue Next Year
$1.64
$12.88
P/E Ratio
$32.62
$10.72
Revenue Growth
N/A
21.51
52 Week Low
$38.23
$25.52
52 Week High
$59.19
$40.87

Technical Indicators

Market Signals
Indicator
GBX
HRMY
Relative Strength Index (RSI) 51.45 56.76
Support Level $44.84 $25.92
Resistance Level $54.15 $30.96
Average True Range (ATR) 2.04 0.82
MACD 0.28 0.42
Stochastic Oscillator 83.61 91.72

Price Performance

Historical Comparison
GBX
HRMY

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: